Fresh analysis reveals that people who discontinue new weight-loss injections like Wegovy and Mounjaro may regain lost weight far faster than those who stop conventional lifestyle programs.
Findings released in a prominent medical journal points out that while obese people often shed substantial amounts of their body weight while using the jabs, the weight comes back at an average rate of nearly a kilo each month once they quit.
"People purchasing these medications must be aware of the danger of fast weight regain when the therapy ends," cautioned expert Dr. Susan Jebb.
This pace of regain implies a reversion to starting weight in about one and a half years.
Analyzing Approaches
The study, which looked at 37 of studies involving thousands of participants, contrasted the outcomes of GLP-1 agonists with conventional dieting.
Researchers point out that individuals who lose weight through lifestyle changes alone generally experience a more gradual weight regain—around 0.1 kg a month—post-intervention.
The Reason for the Rapid Regain
Experts propose the mode of action of the injections explains the amplified regain.
GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which moderates feelings of fullness.
"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the system to produce less of its endogenous hormone, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this hormone supplement means hunger is uncontrolled, making binge eating a significant risk."
An Ongoing Disease?
The NHS advise the injections for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians contend that, considering the significant potential of weight regain, the treatment is often long-term.
This perspective is supported by pharmaceutical companies, who note that the findings "highlight the persistent nature of excess weight," akin to managing diseases like diabetes.
User Experiences
People who have discontinued the medication explain a powerful return of cravings.
"I experienced something flipping and you're instantly extremely hungry," described one woman.
The struggle is exacerbated if individuals have not adopted lasting lifestyle or habit changes during treatment.
Significant Interest
Survey data indicate that a significant number of adults in the UK have tried weight-loss jabs in the past year, with demand remaining high.
- Use is greater among females than men.
- The middle-aged demographic shows the highest level of interest.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
In conclusion, clinicians caution that while GLP-1 drugs are effective tools for shedding pounds, they are not a permanent cure and lasting health benefits hinges on combined lifestyle support.
